Arif Kamal: A leading barrier to accessing state-of-the-art treatment and clinical trials is housing

Uwe Platzbecker: He is a role model for how important patient participation and clinical trials are

Peter Lebowitz: Three Phase 3 lung cancer readouts in the Presidential Symposium and 4 late-breaker presentations in genitourinary cancers

Elsa Anagnostou: Pleased to see stage 1 of our ctDNA molecular response adaptive clinical trial in print.

Vivek Subbiah: Still remember the 1st ever patient enrolled on the trial in the peak of the pandemic.

Raffaele Colombo: ADC history.

Ishwaria Subbiah: Such a pleasure to help kickoff the Texas Society of Clinical Oncology’s 2023 Annual Meeting.

Sonja Loges: This weekend the DKFZ German Cancer Research Center was hosting the NCT 2nd National Conference Patients as Research Partners – entirely organized by patient experts.

TIGIT bispecific program is advancing in clinical trials for non-small cell lung and gastric cancers. – Agenus

Shruti Patel: Had a great time co-leading the Clinical Trial Design work group at Stanford’s Think Tank on Diversity & Health Equity in Clinical Trials!